Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO 
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal 
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025 
Trump Family Files $10 Billion Lawsuit Over IRS Tax Disclosure 
FDA Approves Mitapivat for Anemia in Thalassemia Patients 
Gold and Silver Prices Climb in Asian Trade as Markets Eye Key U.S. Economic Data 
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility 
Newly Released DOJ Epstein Files Expose High-Profile Connections Across Politics and Business 
U.S. Condemns South Africa’s Expulsion of Israeli Diplomat Amid Rising Diplomatic Tensions 
Meta Faces Lawsuit Over Alleged Approval of AI Chatbots Allowing Sexual Interactions With Minors 
Federal Judge Blocks Trump Administration Move to End TPS for Haitian Immigrants 
Johnson & Johnson (J&J) has sued drug distributors and a pharmacy seeking to stop the sale of counterfeit versions of its HIV drugs, and at least $25 million in damages from each defendant.
Patients complaining about receiving the wrong pills in their prescription bottles led J&J to discover widespread counterfeiting, as did the voluntary return of hundreds of bottles of counterfeit pharmaceuticals from one of the defendants, distributor ProPharma Distribution LLC.
Following Gilead Sciences Inc.'s lawsuit in January, the firm said it became aware of the sale of counterfeit versions of its HIV medications. Symtuza, a multi-drug combination treatment, as well as Prezcobix, Prezista, and Edurant, are among the medications at issue.
J&J claims that counterfeit bottles occasionally included a different HIV medicine than what was advertised on the label and that one counterfeit bottle contained the strong antipsychotic Seroquel.
The defendants include ProPharma, Safe Chain Solutions LLC, and Scripts Wholesale Inc, as well as drugstore operator I Care Pharmacy 14 and the business' individual proprietors.
According to the lawsuit, I Care Pharmacy had a physical location in New York City that was closed down immediately after a fraudulent transaction was found.
J&J believes the pharmacy is linked to a criminal counterfeiting network that is still operational in New York City, dispensing hazardous counterfeit HIV medication.
